You are here

large B-cell lymphoma

Gilead’s Yescarta extends survival in lymphoma study

BioPharma Dive

Tue, 03/21/23 - 09:53 pm

Gilead Sciences

large B-cell lymphoma

FDA advisers question efficacy of Roche’s Polivy in first line LBCL

BioSpace

Wed, 03/8/23 - 11:30 am

large B-cell lymphoma

Amidst Legal Battle, BMS' CAR-T Therapy Scores Second FDA Approval

BioSpace

Mon, 06/27/22 - 06:32 pm

Bristol Myers Squibb

large B-cell lymphoma

AbbVie preps filings for lymphoma bispecific licensed from Genmab

Pharmaforum

Thu, 04/14/22 - 10:39 am

large B-cell lymphoma

Gilead beats BMS to FDA okay for early lymphoma CAR-T therapy

Pharmaforum

Mon, 04/4/22 - 10:18 am

Gilead Sciences

Bristol Myers Squibb

large B-cell lymphoma

BMS will file for earlier-line use of Breyanzi in lymphoma after trial win

Pharmaforum

Fri, 06/11/21 - 10:49 am

Bristol Myers Squibb

large B-cell lymphoma

Gilead Sciences

Beefing up its CAR-T pipeline, Gilead teams up with Pfizer on a lymphoma combo

Endpoints

Thu, 01/18/18 - 10:06 am

Gilead Sciences

large B-cell lymphoma

Move over, Novartis: Kite and Gilead break into CAR-T market with early axi-cel nod

Fierce Pharma

Thu, 10/19/17 - 09:12 am

Gilead Sciences

non-Hodgkin's lymphoma

large B-cell lymphoma

Late-stage study of Roche's Gazyva in large B-cell lymphoma fails to hit main goal

First Word Pharma

Mon, 07/18/16 - 10:55 am

large B-cell lymphoma

clinical trials

Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint

The Fly on the Wall

Mon, 05/19/14 - 03:17 pm

large B-cell lymphoma

Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers

Yahoo/BusinessWire

Sat, 12/7/13 - 12:47 pm

large B-cell lymphoma

T-cell acute lymphoblastic leukemia

Infinity Pharmaceuticals